Ken Griffin’s Cue Biopharma CUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6007 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6094 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6111 |
|
|
2024
Q3 | – | Sell |
-83,277
| Closed | -$103K | – | 5920 |
|
|
2024
Q2 | $103K | Sell |
83,277
-62,959
| -43% | -$78.1K | ﹤0.01% | 4937 |
|
|
2024
Q1 | $276K | Buy |
146,236
+95,418
| +188% | +$180K | ﹤0.01% | 4486 |
|
|
2023
Q4 | $134K | Sell |
50,818
-48,377
| -49% | -$128K | ﹤0.01% | 4776 |
|
|
2023
Q3 | $228K | Buy |
99,195
+12
| +0% | +$28 | ﹤0.01% | 4457 |
|
|
2023
Q2 | $362K | Sell |
99,183
-6,476
| -6% | -$23.6K | ﹤0.01% | 3939 |
|
|
2023
Q1 | $377K | Buy |
105,659
+89,641
| +560% | +$320K | ﹤0.01% | 4103 |
|
|
2022
Q4 | $45.7K | Buy |
+16,018
| New | +$45.7K | ﹤0.01% | 5304 |
|
|
2022
Q3 | – | Sell |
-204,043
| Closed | -$508K | – | 5998 |
|
|
2022
Q2 | $508K | Buy |
204,043
+191,694
| +1,552% | +$477K | ﹤0.01% | 4117 |
|
|
2022
Q1 | $60K | Sell |
12,349
-9,012
| -42% | -$43.8K | ﹤0.01% | 5843 |
|
|
2021
Q4 | $242K | Buy |
+21,361
| New | +$242K | ﹤0.01% | 5311 |
|
|
2021
Q3 | – | Sell |
-21,755
| Closed | -$253K | – | 6459 |
|
|
2021
Q2 | $253K | Buy |
+21,755
| New | +$253K | ﹤0.01% | 5365 |
|
|
2021
Q1 | – | Sell |
-27,850
| Closed | -$348K | – | 6326 |
|
|
2020
Q4 | $348K | Sell |
27,850
-189,592
| -87% | -$2.37M | ﹤0.01% | 4118 |
|
|
2020
Q3 | $3.27M | Sell |
217,442
-55,440
| -20% | -$834K | ﹤0.01% | 1838 |
|
|
2020
Q2 | $6.69M | Buy |
272,882
+253,859
| +1,334% | +$6.22M | ﹤0.01% | 1323 |
|
|
2020
Q1 | $270K | Buy |
+19,023
| New | +$270K | ﹤0.01% | 3868 |
|